Jul 27, 2022 / 12:00PM GMT
Operator
Good day, and thank you for standing by. Welcome to the Teva Second Quarter Financial Results Conference Call. (Operator Instructions) Please be advised that today's conference is being recorded. I would now like to hand the conference over to your first speaker today, [Ron Mannix], Senior Vice President, Head of Investor Relations. Please go ahead.
Kevin C. Mannix - Teva Pharmaceutical Industries Limited - SVP of IR
Thank you, Sandra. Thank you, everyone, for joining us today. We all have had an opportunity to review our press release, which was issued yesterday. A copy of this press release as well as a copy of the slides being presented on this call can be found on our website at tevapharm.com. I am joined today on the call by Kare Schultz, Teva's CEO, Eliyahu Kalif, our CFO; and Sven Dethlefs, Head of North America business. We have today acquired a busy agenda. We will start the call with an update from Kare on the progress achieved on the operations front. This will be followed by cause and (inaudible) review of the second quarter business and financial
Q2 2022 Teva Pharmaceutical Industries Ltd Earnings Call Transcript
Feb 11, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers